EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

m 6 A in adipose tissue inflammation: A novel regulator of obesity and metabolic diseases (Review)

Xiaoting Yang, Xiaodan Wang, Haojun Tang, Shuangxi Tu, Kai Yin, Xiao Zhu

International Journal of Molecular Medicine · 2026

DOI: 10.3892/ijmm.2026.5795 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, 2026. Verfasst von Xiaoting Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Diabetic Systems Medicine, Guilin Medical University, Guilin, Guangxi 541199, P.R. China. Hauptthemen laut MEDLINE: Obesity, Adipose Tissue, Inflammation, Metabolic Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adipose tissue hypertrophy, the local infiltration of immune cells, the increased production of proinflammatory cytokines, the whitening of brown adipose tissue, local hypoxia and angiogenesis disorders occur in obese individuals, which in turn lead to adipose tissue inflammation and promote the occurrence and development of metabolic diseases such as type 2 diabetes (T2dM), atherosclerosis and metabolic dysfunction-associated steatotic liver disease (MASLd).In recent years, N6-methyladenine (m 6 A), the most representative epigenetic modification, has been shown to be significantly altered in individuals with obesity and to participate in the regulation of various metabolic diseases.In the present review, the links between m 6 A modification and obesity-related metabolic diseases, such as MASLd and T2dM, from the perspective of adipose tissue inflammation are examined.Additionally, the challenges and prospects associated with targeting m 6 A in adipose tissue inflammation and metabolic diseases are discussed to provide new ideas for the treatment of these conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityAdipose TissueInflammationMetabolic DiseasesHumansAnimalsRNA MethylationDiabetes Mellitus, Type 2Epigenesis, Genetic

Stichwörter der Autor:innen

N6 methyladenineadipogenesisadipose tissue inflammationangiogenesisbrowningmacrophagesmetabolic dysfunction‑associated steatotic liver diseasetype 2 diabeteswhiting

Autor:innen und Institutionen

  • Guangxi Key Laboratory of Diabetic Systems Medicine, Guilin Medical University, Guilin, Guangxi 541199, P.R. China.
  • Department of General Practice, The Fifth Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong 510900, P.R. China.

Zitieren

APA

Yang, X., Wang, X., Tang, H., Tu, S., Yin, K., & Zhu, X. (2026). m 6 A in adipose tissue inflammation: A novel regulator of obesity and metabolic diseases (Review). International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2026.5795

Vancouver

Yang X, Wang X, Tang H, Tu S, Yin K, Zhu X. m 6 A in adipose tissue inflammation: A novel regulator of obesity and metabolic diseases (Review). International Journal of Molecular Medicine. 2026. doi:10.3892/ijmm.2026.5795

BibTeX
@article{Yang2026,
  author = {Yang, Xiaoting and Wang, Xiaodan and Tang, Haojun and Tu, Shuangxi and Yin, Kai and Zhu, Xiao},
  title = {m 6 A in adipose tissue inflammation: A novel regulator of obesity and metabolic diseases (Review)},
  journal = {International Journal of Molecular Medicine},
  year = {2026},
  doi = {10.3892/ijmm.2026.5795}
}
Kostenlos starten →